CLOSE X

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE1578.2578.35 (+5.22 %)
PREV CLOSE ( ) 1499.90
OPEN PRICE ( ) 1514.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 122838
TODAY'S LOW / HIGH ( )1503.00 1599.00
52 WK LOW / HIGH ( )1106.4 1599
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 17-08 1935
Management Info
Y K Hamied - Chairman Umang Vohra - Managing Director
Registered Office

Address Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel,
Mumbai,
Maharashtra-400013

Phone 022-24826000

Email contactus@cipla.com

Website www.cipla.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg, MCX
NEWS
26Jul Cipla informs about disclosure
Cipla has informed that the exchange has received the disclosure under R..
26Jul Cipla informs about disclosure
Cipla has informed that it enclosed disclosure under Regulation 29(1) of..
25Jun Cipla informs about updates
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
25Jun USFDA classifies Cipla’s Patalganga ma
United States Food and Drug Administration (USFDA) has classified Cipla’..
22Jun USFDA conducts inspection at Cipla’s m
The United States Food and Drug Administration (USFDA) has conducted an..
Financials
Rs. in Millions
QTR Jun 24 ANNUAL 24
Net Profit10559.440772.5
Gross Profit 14304.5 49469.7
Operating Profit 15733.855548.1
Net Sales 45010.5165743.4
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 28637.90 (2.27%)
M.Cap ( in Cr)60853.54
Divi's Lab (BSE)
 4792.15 (5.33%)
M.Cap ( in Cr)127216.53
Astrazeneca Pharma I (BSE)
 7173.30 (3.40%)
M.Cap ( in Cr)17933.25
Alkem Laboratories (BSE)
 5295.80 (2.26%)
M.Cap ( in Cr)63319.23
Hester Biosciences (BSE)
 3206.45 (3.67%)
M.Cap ( in Cr)2727.68
Shareholding Pattern
PROMOTERS 30.91%
MUTUAL FUNDS/UTI 17.62%
NON-INSTITUTION 16.4%
FI/BANKS/INSURANCE 5.28%
GOVERNMENT 0%
FII 0%

Badjate Stock & Shares Pvt. Ltd.
201, Mangalam Arcade,
Above Venus Book Centre, Dharampeth Extn. Nagpur - 440010 Maharashtra, India.

Advisory for Investors Complaints Data June 2024 Broking Complaints Data June 2024 PMS Complaints Data June 2024 DP

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal(https://scores.gov.in/scores/Welcome.html)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341 / 57500000546632
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS|KYC |IPO |CLIENT BANK A/C

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.